Omzet 2024 * | 60,47 mld. 56,28 mld. | Omzet 2025 * | 62,71 mld. 58,37 mld. | Marktkapitalisatie | 158 mld. 147 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 7,28 mld. 6,78 mld. | Nettowinst (verlies) 2025 * | 10,81 mld. 10,06 mld. | EV/omzet 2024 * | 3,59 x |
Nettoschuld 2024 * | 59,14 mld. 55,04 mld. | Nettoschuld 2025 * | 54,22 mld. 50,47 mld. | EV/omzet 2025 * | 3,38 x |
K/w-verhouding 2024 * |
20,5
x | K/w-verhouding 2025 * |
14
x | Werknemers | - |
Dividendrendement 2024 * |
6% | Dividendrendement 2025 * |
6,12% | Vrij verhandelbaar | 59,05% |
Recentste transcriptie over Pfizer Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 01-01-93 |
David Denton
DFI | Director of Finance/CFO | 59 | 02-05-22 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 66 | 01-04-20 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 23-02-17 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 27-09-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,55% | 823 mld. | |
+42,31% | 641 mld. | |
-6,83% | 352 mld. | |
+17,15% | 324 mld. | |
+7,09% | 301 mld. | |
+14,02% | 241 mld. | |
+1,64% | 223 mld. | |
+13,66% | 218 mld. | |
+7,87% | 167 mld. |